Cardiovascular Anastomosis Devices Market Growth & Trends
The global cardiovascular anastomosis devices market size is expected to reach USD 2.54 billion by 2030, based on a new report by Grand View Research, Inc. Additionally, the industry is projected to expand at a CAGR of 6.5% from 2022 to 2030. The prevalence of cardiovascular diseases is on the rise globally. They are one of the top three causes of death worldwide, being responsible for around 32% of the total global mortalities.
The adoption of anastomotic devices decreases the extent of aortic manipulation required for creating a graft based on aortic inflow. Hence, surgeons can safely construct aortocoronary grafts. Long-term graft patency is important in cardiovascular surgeries. Patient outcomes after cardiac surgeries are dependent on the quality of the anastomosis surgical techniques. These devices facilitate the anastomoses through minimal incisions.
Cardiac surgery patients were at an increased risk of COVID-19 during the pandemic; therefore, hospital admissions for elective procedures were reduced to prevent potential hospital-acquired infections. At the beginning of the pandemic, only emergency cardiovascular surgeries were allowed to operate, based on the surgical priority of the patient cases. As all the elective cardiac procedures were canceled, the overall market experienced a slowdown. According to the Society of Thoracic Surgeons Adult Cardiac Surgery, there was a significant reduction in adult cardiac surgeries.
Cardiovascular Anastomosis Devices Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook